Virios Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2024 | 2 | -$0.05 | -$0.04 | -$0.05 |
| Q3 2024 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
Virios Therapeutics, Inc. Earnings Date And Information
Virios Therapeutics, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.07 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Virios Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -0.76. Virios Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Virios Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2024 | Q1 2024 | -$0.05 | $0 | $0 | ||
| 05/10/2024 | Q4 2023 | -$0.07 | $0 | |||
| 03/08/2024 | Q3 2023 | -$0.06 | $0 | |||
| 11/13/2023 | Q2 2023 | -$0.10 | -$0.06 | 0.04 | $0 | |
| 08/11/2023 | Q1 2023 | -$0.08 | $0 | |||
| 05/12/2023 | Q4 2022 | -$0.08 | $0 | |||
| 03/14/2023 | Q3 2022 | -$0.16 | -$0.11 | 0.05 | $0 | |
| 11/14/2022 | Q2 2022 | -$0.49 | -$0.28 | 0.21 | $0 | |
| 08/12/2022 | Q1 2022 | -$0.44 | $0 | |||
| 05/13/2022 | Q4 2021 | -$0.48 | $0 | |||
| 03/18/2022 | Q3 2021 | -$0.54 | $0 | |||
| 11/12/2021 | Q2 2021 | -$0.49 | $0 | |||
| 08/13/2021 | Q1 2021 | -$0.51 | $0 | |||
| 05/14/2021 | Q4 2020 | -$0.37 | $0 | |||
| 03/23/2021 | Q3 2020 | -$1.25 | $0 | |||
| 09/29/2020 | Q2 2020 | -$0.35 | $0 | |||
| 06/29/2020 | Q1 2020 | -$0.14 | $0 | |||
| 03/30/2020 | Q4 2019 | -$0.10 | $0 | |||
| 12/30/2019 | Q3 2019 | -$0.13 | $0 | |||
| 09/29/2019 | Q2 2019 | -$0.17 | $0 |
Virios Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Virios Therapeutics, Inc.'s earnings date?
Virios Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Virios Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Virios Therapeutics, Inc. (:VIRI) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.07 by $0.02.
-
How can I listen to Virios Therapeutics, Inc.'s earnings conference call?
The conference call for Virios Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Virios Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Virios Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Virios Therapeutics, Inc. generate each year?
Virios Therapeutics, Inc. (:VIRI) has a recorded net income of $0. Virios Therapeutics, Inc. has generated $-0.28 earnings per share over the last four quarters.
-
What is Virios Therapeutics, Inc.'s price-to-earnings ratio?
Virios Therapeutics, Inc. (:VIRI) has a price-to-earnings ratio of -0.76 and price/earnings-to-growth ratio is -0.05.
